FLAVIE SOINS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
FLAVIE SOINS
Largest movements
- Cash +€13,010
up €13,010 (+3,244%), from €401 to €13,411
mainly Net result for the year (+€8,559) and Receivables within one year (+€5,004)
- Receivables within one year -€5,004
down €5,004 (-34.1%), from €14,676 to €9,672
of which Other amounts receivable: -€3,175
- Reserves +€8,000
up €8,000 (+34.0%), from €23,500 to €31,500
- Trade debts -€1,622
down €1,622 (-55.1%), from €2,945 to €1,323
- Tax, wage and social debts +€870
up €870 (+12.5%), from €6,985 to €7,855
- Profit (loss) carried forward +€559
up €559 (+63.5%), from €880 to €1,439
- Gross operating margin +€9,289
up €9,289 (+176%), from €5,290 to €14,578
- Taxes +€2,992
up €2,992 (+121%), from €2,477 to €5,469
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €35,810 | €43,617 | +€7,807 | +21.8% |
| Formation expenses | 20 | €0 | €0 | = | |
| Current assets | 29/58 | €35,810 | €43,617 | +€7,807 | +21.8% |
| Amounts receivable after more than one year | 29 | €20,533 | €20,533 | = | 0.0% |
| Other amounts receivable | 291 | €20,533 | €20,533 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €14,676 | €9,672 | -€5,004 | -34.1% |
| Trade receivables | 40 | €1,828 | - | -€1,828 | |
| Other amounts receivable | 41 | €12,847 | €9,672 | -€3,175 | -24.7% |
| Cash at bank and in hand | 54/58 | €401 | €13,411 | +€13,010 | +3,244% |
| Deferred charges and accrued income | 490/1 | €200 | - | -€200 | |
| Total equity and liabilities | 10/49 | €35,810 | €43,617 | +€7,807 | +21.8% |
| Equity | 10/15 | €25,880 | €34,439 | +€8,559 | +33.1% |
| Contributions | 10/11 | €1,500 | €1,500 | = | 0.0% |
| Reserves | 13 | €23,500 | €31,500 | +€8,000 | +34.0% |
| Distributable reserves | 133 | €23,500 | €31,500 | +€8,000 | +34.0% |
| Profit (loss) carried forward | 14 | €880 | €1,439 | +€559 | +63.5% |
| Amounts payable | 17/49 | €9,930 | €9,178 | -€752 | -7.6% |
| Amounts payable within one year | 42/48 | €9,930 | €9,178 | -€752 | -7.6% |
| Trade debts | 44 | €2,945 | €1,323 | -€1,622 | -55.1% |
| Suppliers | 440/4 | €2,945 | €1,323 | -€1,622 | -55.1% |
| Advances received on contracts in progress | 46 | €0 | - | = | |
| Taxes, remuneration and social security | 45 | €6,985 | €7,855 | +€870 | +12.5% |
| Taxes | 450/3 | €6,985 | €7,855 | +€870 | +12.5% |
| Other amounts payable | 47/48 | €0 | - | = | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €0 | - | = | |
| Other operating charges | 640/8 | €384 | €397 | +€13 | +3.3% |
| Gross operating margin | 9900 | €5,290 | €14,578 | +€9,289 | +176% |
| Operating profit (loss) | 9901 | €4,905 | €14,181 | +€9,276 | +189% |
| Financial income | 75/76B | €0 | - | = | |
| Recurring financial income | 75 | €0 | - | = | |
| Financial charges | 65/66B | €153 | €154 | +€1 | +0.4% |
| Recurring financial charges | 65 | €153 | €154 | +€1 | +0.4% |
| Profit (loss) for the period before taxes | 9903 | €4,752 | €14,027 | +€9,276 | +195% |
| Income taxes | 67/77 | €2,477 | €5,469 | +€2,992 | +121% |
| Profit (loss) for the period | 9904 | €2,275 | €8,559 | +€6,283 | +276% |
| Profit (loss) for the period to be appropriated | 9905 | €2,275 | €8,559 | +€6,283 | +276% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.